Alyeska Investment Group »

Immunovant shares owned by Alyeska Investment Group

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Alyeska Investment Group from 13F filings

Historical chart of Alyeska Investment Group investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Alyeska Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Alyeska Investment Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.6M 62k 42.13
2021-03-31 $6.1M 377k 16.04

More positions owned by Alyeska Investment Group

Oracle Corporation (ORCL)
Alphabet Cap Stk Cl A (GOOGL)
Twilio Cl A Call Option (TWLO)
Ulta Salon, Cosmetics & Fragrance (ULTA)
Take-Two Interactive Software (TTWO)
Wal-Mart Stores (WMT)
Broadcom (AVGO)
Astrazeneca Sponsored Adr (AZN)
Adobe Systems Incorporated (ADBE)
Burlington Stores (BURL)
3M Company (MMM)
Lauder Estee Cos Cl A (EL)
Dollar General (DG)
Amazon (AMZN)
Dell Technologies CL C (DELL)

View all positions for Alyeska Investment Group

Top funds holding Immunovant

FMR
Vanguard Group
BlackRock
Perceptive Advisors
Armistice Capital
T. Rowe Price Associates
Viking Global Investors
Logos Global Management
Alpine Partners VI
Point72 Asset Management
Geode Capital Management
Woodline Partners
Fred Alger Management
Pictet Asset Management Holding SA
Rock Springs Capital Management

View all funds holding Immunovant